Companion Animal Arthritis Market Size & Share 2024 - 2032

Companion Animal Arthritis Market Size

The global companion animal arthritis market size was valued at USD 3.4 billion and is estimated to grow at a CAGR of 7.2% from 2024 to 2032. Arthritis in animals is defined as inflammation and degeneration of the joints and is a common ailment in pets like dogs and cats.

Its symptoms include pain, and stiffness which brings down the mobility level of the pet. The rising levels of pet ownership led to an increasing diagnosis of arthritis in companion animals such as dogs and cats. The rise of pet ownership is one of the most contributive factors to the uptick in the companion animal industry. Also, the steep rise in pet ownership has resulted in increased rates of companion animal healthcare products such as medications and supplements.
 

Additionally, the global surge in pet adoption along with improved means of veterinary medicine diagnostics and treatment is driving market growth. The rise in technological advancement and rise in adoption of advanced diagnostic and disease monitoring products have enhanced treatment regimen led to manage more disease conditions and thus contributing to market growth.
 

Companion Animal Arthritis Market Trends

Veterinary clinics are now incorporating novel technologies such as MRI and CT scans for accurate diagnosis of joint conditions in pets. These revolutionary tools enable veterinarians to develop better treatment approaches by providing them with better understanding of the anatomy of the joints.
 

• Effective diagnostic tools and treatment techniques are being sought to address the increasing cases of arthritis in pets. For instance, according to recent studies conducted by veterinary scientists 90% of cats and 20% of dogs will develop arthritis as they age. In addition, a considerable portion of pets aged over seven years are bound to show signs of arthritis.
   
• Therefore, rising cases of arthritis along with the launch of new therapies and devices such as laser treatment, advanced rehabilitation programs and activity monitors are fostering the segmental growth.
   

Companion Animal Arthritis Market Analysis

Based on treatment type, the market is segmented into medication, food supplement, surgery, and other treatment types. The medication segment is further bifurcate into NSAIDs, monoclonal antibodies, and other medications. The medication segment is estimated to account for USD 1.5 billion in 2023.
 

• The arthritis in companion animals is treated by veterinary clinicians using pharmaceutical medications, which include NSAIDs, corticosteroids, and disease-modifying osteoarthritis drugs (DMOADs), with the aim to relieve pain and inflammation.
   
• Technological advancement in veterinary medicine leads to development of faster, more accurate and comprehensive drugs for better treatment plans.
   
• Medication segments are currently dominating the market, owing to benefits offered such as extended treatments and availability of alternative medicines for promoting joint health and mobility.
   
• The adoption of biologic treatments like monoclonal antibodies and stem cell therapy has enhanced the arthritis treatment methodologies for companion animals, thereby fueling the growth of the market.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on disease type the companion animal arthritis market is segmented into osteoarthritis, rheumatoid arthritis, and other arthritis types. The osteoarthritis segment dominated the market with the market share of 64.3% in 2023.
 

• Osteoarthritis is a widely prevalent joint disease and may be observed in about 20% of older dogs and cats and is characterized by degenerative changes in articular cartilage and bone.
   
• The rising inclination of consumers towards holistic and natural treatment options is likely to increase the demand for supplements such as glucosamine, chondroitin, and omega-3 fatty acids. This will help manage canine osteoarthritis, thus propelling the growth of the market.
   

Based on animal type the companion animal arthritis market is segmented into dogs, cats, and other animals. The dogs’ segment is expected to reach USD 4.5 billion by 2032.
 

• Certain types of dogs are more prone to arthritis such as older labradors and german shepherds. With an increase in the rate of adoption of pets, expenses related to pet healthcare facilities and products are also on the rise.
   
• Further, the animal arthritis treatment market is experiencing rapid growth which is sustained by new market developments geared toward enhancing pet dogs' quality.
   

Based on end use, the companion animal arthritis market is segmented into veterinary hospitals, veterinary clinics, veterinary rehabilitation centers, and other end users. The veterinary hospitals segment is expected to exhibit 7.3% CAGR between 2024 – 2032.
 

• Veterinary hospitals are equipped to perform a variety of veterinarian services ranging from surgical procedures to physical therapy, as well as monitoring the progression of arthritis in the patients. For arthritis management, pet owners rely on veterinarians for expert advice on cases including treatment types and dosage.
   
• With changes in lifestyle to prioritize health for companion animals, more people are owning pets, which is further propelling the market for veterinary services. These include general examinations, vaccination shots, and arthritis management.
   
• With increased visitations to the veterinary hospitals, there is a consequent increased need for drugs and treatments which in turn stimulates market growth.
   

In 2023, North America commanded a dominant 45.6% share of the global companion animal arthritis market, with projections indicating robust growth throughout the analysis period.
 

• Increasing pet population, integrated concern towards animal healthcare, and modern veterinary services are major growth contributors for the market in North America. Also, in both urban and rural parts of America, pet owners have easy access to healthcare services due to an extensive network of veterinary clinics and hospitals.
   
• Further, the region benefits from a strong market for pet pharmaceuticals, with major companies developing and launching new medications specifically targeted at managing osteoarthritis in dogs. These include both symptomatic treatments and disease-modifying drugs, which slow the progression of the disease.
   

Germany is poised to lead in growth within the European companion animal arthritis market.
 

• Pets are common in many German households, which makes the country one of the highest pet-owning nations in Europe. This shift in demographics makes it very suitable for an increase in spending on veterinary services like treating arthritis.
   
• With Germany's technological progress in diagnostics, therapeutics, and surgical processes, veterinary medicine is undergoing an enhancement, which allows for arthritis and other companion animal conditions to be treated on a wider scale.
   

In the Asia-Pacific region, the companion animal arthritis market is projected to grow at a notable CAGR of 7.6% during the forecast period.
 

• Veterinarians within the Asia Pacific region are adopting innovative technologies from medication and therapy for arthritis treatment to modern diagnostic methods, which enhances the availability of specialist care.
   
• In the Asia Pacific region, economic development and growth in disposable incomes is leading to increased expenditure on pet care. There is a noticeable shift in pet owners as many are now willing to pay for advanced pet treatments and therapies, which in turn aids in economic growth.
   

Companion Animal Arthritis Market Share

The market has many large and mid-sized companies which strive to gain a competitive advantage within the industry. One effective strategy to gain market share is the introduction of technologically advanced products. Several of the major global market players have an established foothold in the region.
 

Companion Animal Arthritis Market Companies

Prominent players operating in the market are as mentioned below:

• American Regent, Inc.
• Bayer AG (Bayer Animal Health)
• Boehringer Ingelheim International GmbH
• CEVA Santé Animale
• Dechra Pharmaceuticals plc
• Elanco Animal Health Incorporated
• Eltech K-Laser s.r.l.
• Medivet
• Norbook Laboratories Ltd.
• Nutramax Laboratories Veterinary Sciences, Inc
• Vetoquinol SA
• Vibrac
• Zoetis, Inc.
   

USPs for top market players:

• Innovative products offering by key market players
• Customized product designing for specific species and weight for accurate dosing
• Strong distribution channel to ensure easy access of products
   

Companion Animal Arthritis Industry News:

• In June 2023, Zoetis launched a new monoclonal antibody therapy for treating canine osteoarthritis. This treatment aims to provide long-lasting pain relief for dogs with arthritis by targeting nerve growth factor (NGF). This introduction expanded Zoetis's product offerings.
   

The companion animal arthritis market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Treatment Type

• Medication
  • NSAIDs
  • Monoclonal antibodies
  • Other medications
• Food supplement
• Surgery
• Other treatment types

Market, By Disease Type

• Osteoarthritis
• Rheumatoid arthritis
• Other arthritis types

Market, By Animal Type

• Dogs
• Cats
• Other animals

Market, By End Use

• Veterinary hospitals
• Veterinary clinics
• Veterinary rehabilitation centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherland
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa